Publications by authors named "Ayumu Hagiwara"
Transplant Proc
August 2024
Article Synopsis
- The study compared the effectiveness and safety of new anemia treatments (HIF-PHis) in chronic kidney disease (CKD) patients who have received kidney transplants (KTRs) versus those who have not (non-KTRs).
- Researchers analyzed data from 82 patients before and after starting treatment with roxadustat or daprodustat, focusing on hemoglobin (Hb) levels and adverse events.
- Findings showed both groups had significant increases in Hb levels, but KTRs had a higher rate of thrombotic events, indicating that while the treatments are similarly effective, KTRs require careful monitoring for blood clot risks.
